HCPCS Q4074 is officially defined as "Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms." No tracked policy changes reference HCPCS Q4074 yet. New payer updates are added daily, so check back soon or create a free alert to be notified the moment a change affects this code.
No tracked policy changes match this filter yet. New policies are added daily.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.